For ablative CO₂ or Er:YAG resurfacing, clinicians should prescribe systemic antiviral prophylaxis for every patient, regardless of reported HSV history. A commonly used regimen is valacyclovir 500 mg twice daily, famciclovir 250 mg twice daily, or acyclovir 400 mg three times daily. Start treatment the day before treatment or on the morning of the procedure and continue for 7–10 days, or until complete re-epithelialization, whichever is longer.
Ablative resurfacing removes or severely disrupts the epidermal barrier, allowing HSV to reactivate or cause primary infection across the treated surface. Universal oral prophylaxis, started perioperatively and continued through epithelial recovery, is the central prevention strategy.
Why Ablative Resurfacing Requires Prophylaxis
Barrier disruption increases HSV risk
Fully ablative CO₂ and Er:YAG treatments remove the stratum corneum and produce thermal injury. During healing, the exposed or damaged skin can support rapid HSV spread and may delay wound healing.
HSV reactivation can occur even when the patient has never reported cold sores. A patient’s negative history therefore does not reliably exclude risk.
Dissemination can worsen outcomes
A herpetic eruption over a de-epithelialized treatment field may be extensive rather than localized. Potential consequences include significant pain, delayed epithelialization, scarring, and pigmentary changes.
The risk is particularly important with full-face and perioral treatment, where a large contiguous surface is affected.
Recommended Antiviral Protocol
Use systemic oral therapy
Common prophylactic options include:
- Valacyclovir: 500 mg orally twice daily
- Famciclovir: 250 mg orally twice daily
- Acyclovir: 400 mg orally three times daily
These are standard clinical regimens described for ablative resurfacing. The treating clinician should select the agent and dose after reviewing renal function, allergies, medication interactions, pregnancy or lactation status, and relevant local guidance.
Start before or at treatment
Begin antiviral therapy the day before the procedure or on the morning of treatment. Starting 1–2 days before treatment is also used in some protocols, particularly for patients with a known history of recurrent HSV or when treating a large area.
The important principle is that effective systemic coverage should be present when epidermal disruption occurs.
Continue through epithelial recovery
Continue prophylaxis for 7–10 days and extend it when complete re-epithelialization has not occurred. For extensive or fully ablative treatment, a minimum of 10 days may be appropriate when consistent with the clinician’s protocol and patient-specific assessment.
The endpoint should be based on the clinical healing course rather than an arbitrary date alone.
Treat suspected infection promptly
Prophylaxis reduces risk but does not eliminate it. New grouped vesicles, erosions, disproportionate pain, rapidly spreading ulceration, or delayed healing should prompt immediate clinical assessment and consideration of diagnostic testing and therapeutic antiviral dosing.
A suspected breakthrough infection should not be managed by simply continuing routine prophylaxis without reassessment.
Adjust the Protocol to the Procedure
Full-face and perioral resurfacing
Universal prophylaxis is especially important for full-face or perioral resurfacing because the treatment field is extensive and may permit widespread viral dissemination.
The clinician should use a defined perioperative protocol, document the starting dose and duration, and provide clear instructions for completing the course.
Focal or less extensive treatment
A smaller treatment area may carry a lower absolute risk, but ablative treatment still disrupts the epidermal barrier. The reference protocol supports prophylaxis for ablative CO₂ and Er:YAG resurfacing regardless of HSV history.
The exact duration can be individualized according to treatment depth, surface area, healing progress, and patient risk factors.
Patients with recurrent HSV
A history of frequent or severe HSV outbreaks warrants particular attention to timing, adherence, and follow-up. Starting 1–2 days preoperatively may be selected for higher-risk patients, provided the regimen is appropriate for that individual.
Patients should be told to report prodromal burning, tingling, vesicles, or erosions immediately.
Integrate Antivirals With Wound Care
Protect the recovering barrier
Antiviral prophylaxis addresses HSV risk but does not replace wound care. Gentle cleansing, non-adherent protection when indicated, and frequent application of a clinician-approved emollient barrier ointment help prevent desiccation and support epithelial recovery.
For full-face treatment, barrier care commonly continues until re-epithelialization, often around 10 days, although healing varies.
Monitor the healing course
Follow-up should assess epithelialization, pain, erythema, drainage, vesicles, and signs of bacterial infection. Delayed healing or worsening symptoms require examination rather than assuming a normal post-laser response.
Patient instructions should include the expected recovery pattern and specific symptoms that require urgent contact.
Avoid assuming antibiotics are universally required
The supplementary material includes routine systemic antibiotic prophylaxis, but this is not a universal standard that should automatically accompany every ablative procedure. Broad-spectrum antibiotics should generally be reserved for a clear indication or used according to an established evidence-based institutional protocol.
Antibiotic overuse creates adverse-effect and antimicrobial-resistance risks without necessarily improving outcomes.
Understanding the Trade-offs
Prophylaxis is not risk-free
Oral antivirals can cause adverse effects such as gastrointestinal symptoms, headache, or, rarely, neurotoxicity or renal complications. Dose adjustment is important in renal impairment, particularly with acyclovir and valacyclovir.
Medication selection should account for the patient’s comorbidities, concurrent drugs, and ability to maintain hydration.
Regimens vary across protocols
Published and institutional protocols differ in whether treatment begins on the day of surgery or 1–2 days earlier and whether therapy continues for 7 days, 10 days, or until the skin has fully re-epithelialized. These differences reflect variation in treatment extent, patient risk, and local practice.
Clinicians should standardize their protocol while allowing documented patient-specific adjustments.
Prophylaxis does not replace infection control
Ablative laser procedures also generate a plume from vaporized tissue. Appropriate smoke evacuation, personal protective equipment, room ventilation, and biohazardous-waste handling remain necessary because antiviral therapy does not address occupational exposure.
The smoke-evacuator inlet should be positioned close to the treatment site, and disposable contaminated components should be handled according to applicable infection-control requirements.
How to Apply This to Your Practice
The following approach provides a practical baseline that clinicians can adapt to local policy and patient-specific factors:
- If your primary focus is preventing HSV reactivation: Prescribe oral valacyclovir 500 mg twice daily, famciclovir 250 mg twice daily, or acyclovir 400 mg three times daily for all ablative CO₂ or Er:YAG patients, beginning the day before or the morning of treatment.
- If your primary focus is managing higher-risk patients: Consider starting 1–2 days before treatment for patients with recurrent HSV, extensive full-face treatment, or perioral resurfacing, after reviewing contraindications and renal function.
- If your primary focus is ensuring adequate duration: Continue therapy for 7–10 days and extend it until complete re-epithelialization when healing remains incomplete.
- If your primary focus is detecting complications early: Provide explicit instructions to report vesicles, spreading erosions, disproportionate pain, drainage, or delayed healing and assess suspected breakthrough infection promptly.
- If your primary focus is avoiding unnecessary medication: Do not add routine broad-spectrum antibiotics without a defined indication or evidence-based institutional protocol.
A consistent, patient-adjusted antiviral protocol carried through complete epithelial recovery is the most reliable way to reduce HSV complications after ablative laser resurfacing.
Summary Table:
| Aspect | Recommendation |
|---|---|
| Indication | Universal prophylaxis for all patients undergoing ablative CO₂ or Er:YAG resurfacing |
| Common regimens | Valacyclovir 500 mg PO BID, Famciclovir 250 mg PO BID, Acyclovir 400 mg PO TID |
| Start time | Day before or morning of procedure |
| Duration | 7–10 days or until complete re-epithelialization, whichever is longer |
| Special considerations | Adjust for renal function, pregnancy, drug interactions; extend for high-risk patients |
| Breakthrough infection | Prompt assessment and therapeutic dosing |
Ensure your patients benefit from the latest laser resurfacing protocols. At BELIS, we proudly supply professional-grade medical aesthetic equipment exclusively for clinics and premium salons. Our advanced laser systems—including CO2 Fractional and Erbium lasers—are trusted by practitioners worldwide. Our portfolio also features Diode Hair Removal, Alexandrite, Nd:YAG, Pico, IPL, PDT devices, HIFU, Microneedle RF, body sculpting solutions (EMSlim, Cryolipolysis, RF Cavitation), Hydrafacial systems, and more. Whether you're a clinic aiming to elevate patient care or a distributor seeking high-margin partnerships, we offer OEM/ODM support, certifications, and reliable supply. Discover how BELIS can empower your practice—contact us today to request a personalized quote. Get in touch now!
Related Products
- Fractional CO2 Laser Machine for Skin Treatment
- Fractional CO2 Laser Machine for Skin Treatment
- Cryolipolysis Fat Freezing Cavitation Lipo Laser Machine
- Cryolipolysis Fat Freezing Machine Cavitation Lipo Laser Machine
- Multifunctional Laser Hair Growth Machine Device for Hair Growth
People Also Ask
- What is the technical principle behind CO2 Laser Fractional micro-perforations? Master Scar Revision Mechanics
- What parameters and treatment intervals are advised when applying fractional CO2 laser technology to delicate periorbital skin laxity? Discover safe protocols for eyelid rejuvenation.
- What is the primary function of a high-precision fractional CO2 laser system for GSM? Restore Vaginal Health Naturally
- Why do fractional CO2 laser parameters need to be differentiated? Master Keloid vs. Hypertrophic Scar Treatment
- How should laser power output be adjusted based on tissue vaporization? Mastery of Fractional CO2 Precision
